We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.49B
AUM Growth
-$343M
Cap. Flow
-$249M
Cap. Flow %
-2.94%
Top 10 Hldgs %
16.07%
Holding
2,271
New
51
Increased
125
Reduced
935
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 17.14%
2 Financials 17.01%
3 Healthcare 12.77%
4 Industrials 11.29%
5 Consumer Discretionary 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDXS icon
1801
Codexis
CDXS
$172M
$236K ﹤0.01%
21,463
PEBO icon
1802
Peoples Bancorp
PEBO
$1.48B
$235K ﹤0.01%
6,641
RIGL icon
1803
Rigel Pharmaceuticals
RIGL
$782M
$235K ﹤0.01%
6,627
XOXO
1804
DELISTED
Xo Group Inc
XOXO
$235K ﹤0.01%
11,305
SRDX
1805
DELISTED
Surmodics
SRDX
$234K ﹤0.01%
6,159
MMI icon
1806
Marcus & Millichap
MMI
$1.18B
$233K ﹤0.01%
6,463
MCFT icon
1807
MasterCraft Boat Holdings
MCFT
$600M
$232K ﹤0.01%
9,205
FMSA
1808
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
$232K ﹤0.01%
54,651
-25,520
-32% -$128K
QNST icon
1809
QuinStreet
QNST
$1.19B
$231K ﹤0.01%
18,085
FPRX
1810
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$231K ﹤0.01%
13,422
ANIP icon
1811
ANI Pharmaceuticals
ANIP
$1.73B
$230K ﹤0.01%
3,945
GOOD
1812
Gladstone Commercial Corp
GOOD
$630M
$230K ﹤0.01%
13,243
KE
1813
Kimball Electronics
KE
$606M
$228K ﹤0.01%
14,109
TELL
1814
DELISTED
Tellurian Inc.
TELL
$228K ﹤0.01%
31,583
ABTX
1815
DELISTED
Allegiance Bancshares
ABTX
$228K ﹤0.01%
5,825
CTRL
1816
DELISTED
Control4 Corporation
CTRL
$228K ﹤0.01%
10,604
NXRT
1817
NexPoint Residential Trust
NXRT
$631M
$227K ﹤0.01%
9,154
STFC
1818
DELISTED
State Auto Financial Corp
STFC
$227K ﹤0.01%
7,940
HLNE icon
1819
Hamilton Lane
HLNE
$5.69B
$226K ﹤0.01%
6,064
MYE icon
1820
Myers Industries
MYE
$1.23B
$226K ﹤0.01%
10,665
TTEC icon
1821
TTEC Holdings
TTEC
$77.4M
$226K ﹤0.01%
7,377
ALTA
1822
DELISTED
Altabancorp
ALTA
$226K ﹤0.01%
7,011
FATE icon
1823
Fate Therapeutics
FATE
$317M
$225K ﹤0.01%
+23,078
New +$221K
CORR
1824
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$224K ﹤0.01%
5,980
VRTV
1825
DELISTED
VERITIV CORPORATION
VRTV
$224K ﹤0.01%
5,727

Similar funds

MetLife Investment Management's Q1 2018 Portfolio in Review

As of Q1 2018, MetLife Investment Management held 2,271 positions worth $8.49B, down 3.9% from $8.84B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management's Q1 2018 filing shows 51 new, 125 increased, 935 reduced and 90 closed positions. Its largest new stake was Syneos Health, Inc. Class A Common Stock: 60,685 shares worth $2.15M. The largest sale was Bank of New York Mellon, an estimated $17.1M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q1 2018 buy was Syneos Health, Inc. Class A Common Stock: 60,685 shares worth $2.15M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $25.3M increase.
  • MetLife Investment Management's biggest Q1 2018 reduction was Apple, cutting an estimated $10.6M.
  • MetLife Investment Management fully exited Bank of New York Mellon in Q1 2018, selling an estimated $17.1M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $8.49B portfolio in Q1 2018.
  • MetLife Investment Management opened 51 new positions and closed 90 in Q1 2018.
  • MetLife Investment Management's portfolio value fell 3.9% quarter-over-quarter to $8.49B.

Based on MetLife Investment Management's 13F filing for Q1 2018, filed 15 May 2018.